Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450209) titled 'COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)' on Feb. 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Screening. Masking: None (Open Label).

Primary Sponsor: University of Missouri, Kansas City

Condition: COVID-19 Testing Behaviors

Intervention: Behavioral: COVID-19 rapid test-to-treat

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: May 15, 2024

Target Sample Size: 900

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/stu...